Respiratory syncytial virus immune globulin treatment of RSV lower respiratory tract infection in previously healthy children

Pediatrics

Volumn 100, Issue 6, 1997, Pages 937-942

  Rodriguez, William J ^a   Gruber, William C ^b   Groothuis, Jessie R ^c   Simoes, Eric A F ^c   Rosas, Angela J ^d   Lepow, Martha ^e   Kramer, Andrew ^f   Hemming, Val ^g  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c CHILDREN S HOSPITAL   (United States)

^d WEST VIRGINIA UNIVERSITY   (United States)

^e ALBANY MEDICAL COLLEGE   (United States)

^f MEDIMMUNE   (United States)

^g UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Bronchiolitis; Controlled trial; Lower respiratory tract infections; Randomized; Respiratory syncytial virus; Respiratory syncytial virus immune globulin

Indexed keywords

IMMUNOGLOBULIN; RESPIRATORY SYNCYTIAL VIRUS ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; INFANT; INFECTION PREVENTION; INTENSIVE CARE; LOWER RESPIRATORY TRACT INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; TREATMENT OUTCOME;

EID: 0030658917     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.100.6.937     Document Type: Article

References (30)

1. Brandt CD, Kim HW, Arrobio JO, et al. Epidemiology of respiratory syncytial virus infection in Washington, DC. III. Composite analysis of eleven consecutive yearly epidemics. Am J Epidemiol. 1973;98:355-364
2. Kim HW, Arrobio JO, Brandt CD, et al. Epidemiology of respiratory syncytial virus infection in Washington, DC. I. Importance of the virus in different respiratory disease syndromes and temporal distribution of infection. Am J Epidemiol. 1973;98:216-225
3. Chanock RM, Kim HW, Vargosko AJ, et al. Respiratory syncytial virus. I. Virus recovery and other observations during 1960; outbreak of bronchiolitis, pneumonia, and minor respiratory diseases in children. JAMA. 1961;176:647-653
4. Parrott RH, Kim HW, Arrobio JO, et al. Epidemiology of respiratory syncytial virus infection in Washington, DC. II. Infection and disease with respect to age, immunologic status, race and sex. Am J Epidemiol. 1973;98:289-300
5. Hall CB, McCarthy CA. Respiratory syncytial virus. In: Mandell GL, Douglas RG, Jr, Bennett JE, eds. Principles and Practice of Infectious Diseases. 4th ed. New York, NY: Churchill Livingstone; 1995:1501-1519
6. Institute of Medicine Committee on Issues and Priorities for New Vaccine Development. Prospects for immunizing against respiratory syncytial virus. In: New Vaccine Development, Establishing Priorities, Volume I Diseases of Importance in the United States. Washington, DC: National Academy of Sciences Press; 1988:397-409
7. MacDonald NE, Hall CB, Suffin SC, et al. Respiratory syncytial virus infection in children with congenital heart disease. N Engl J Med. 1982; 307:397-400
8. Hall CB, Powell KR, MacDonald NE, et al. Respiratory syncytial virus infection in children with compromised immune function. N Engl J Med. 1986;315:77-81
9. Eriksson M, Forsgren M, Shoberg S, et al. Respiratory syncytial virus infection in young hospitalized children. Acta Paediatr Scan. 1983;72: 47-51
10. Groothuis JR, Gutierrez KM, Lauer BA. Respiratory syncytial virus infection in children with bronchopulmonary dysplasia. Pediatrics. 1988; 82:199-203
11. Hall CB, Powell KR, Schnabel KC, et al. Risk of secondary bacterial infection in infants hospitalized with respiratory syncytial virus infection. J Pediatr. 1988;113:266-271
12. Cunningham CK, McMillan JA, Gross SJ. Rehospitalization for respiratory illness in infants less than 32 weeks gestation. Pediatrics. 1991;88: 527-532
13. Navas L, Wang E, DeCarvalho V, et al. Improved outcome of respiratory syncytial virus infection in a high risk hospitalized population of Canadian children. J Pediatr. 1992;121:348-354
14. Hall CB, McBride JT, Walsh EE, et al. Aerosolized ribavirin treatment of infants with respiratory syncytial virus infections: a randomized double-blind study. N Engl J Med. 1983;308:1443-1447
15. Hall CB, McBride JT, Gala CL, et al. Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease. JAMA. 1985;254:3047-3051
16. Siber GR, Leombruno D, Leszczynski J, et al. Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin. J Infect Dis. 1994; 169:1368-1373
17. Siber GR, Leszczynski J, Pena-Cruz V, et al. Protective activity of human respiratory syncytial virus immune globulin prepared from donors screened by microneutralization assay. J Infect Dis. 1992;165:456-463
18. Groothuis JR, Simoes EAF, Levin MJ, et al. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. N Engl J Med. 1993;329:1524-1530
19. The PREVENT Study Group. Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. Pediatrics. 1997;99:93-99
20. Prince GA, Jenson AB, Horswood RL, et al. The pathogenesis of respiratory syncytial virus infection in cotton rats. Am J Pathal. 1978;93: 771-783
21. Prince GA, Horswood RL, Camargo E, et al. Mechanisms of immunity to respiratory syncytial virus in cotton rats. Infect Immun. 1983;42:81-87
22. Prince GA, Horswood RL, Camargo E, et al. Immunoprophylaxis and immunotherapy of respiratory syncytial virus in cotton rats. Virus Res. 1987;3:193-206
23. Hemming VG, Prince GA, Horswood RL, et al. Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model. J Infect Dis. 1985;152:1083-1087
24. Hemming VG, Rodriguez W, Kim HW, et al. Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children. Antimicrob Agents Chemother. 1987;31:1882-1886
25. Coates HV, Ailing DW, Chanock RM. An antigenic analysis of respiratory syncytial virus isolates by a plaque reduction neutralization test. Am J Epidemiol. 1966;82:299-313
26. Siber GR, Werner BG, Halsey NA, et al. Interference of immune globulin with measles and rubella immunization. J Pediatr. 1993;122:204-211
27. Sriwatanakul K, Kelvie W, Lassagne L, et al. Studies in different types of visual analog scales for measurement of pain. Clin Pharmacol Ther. 1983;34:234-239
28. Brush GG. How to Choose the Proper Sample Size. Milwaukee, WI: American Society of Quality Control Statistics Division; 1988
29. Prince GA, Porter DD. Treatment of parainfluenza virus type 3 bronchiolitis and pneumonia in a cotton rat model using topical antibody and glucocorticosteroid. J Infect Dis. 1996;173:598-608
30. Rodriguez WJ, Gruber WC, Welliver RC, et al. Respiratory syncytial virus immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections. Pediatrics. 1997;99:454-461